GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.
Verdant Scientific is developing a first-in-class, first-in-approach small molecule for the treatment of atopic dermatitis, more commonly known as eczema, which is poised to completely change the treatment of this chronic, inflammatory skin condition, which affects over 200 million people worldwide.
Labor and Delivery technology that improves risk prediction 10x for postpartum hemorrhage, saving lives, reducing maternal complications and cutting obstetrics costs for health systems and payers.
Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.
Moleculera Biosciences is pioneering the diagnosis, treatment, and monitoring of immune-related neuropsychiatric, cardiovascular, Long-COVID, and neurodegenerative disorders. The complexity of immune-mediated chronic conditions has placed an enormous burden on the healthcare system, which is at the core of the future of human health. We enable clinicians with technologies needed to accurately diagnose, treat, and monitor patients suffering from certain chronic debilitating disorders to experience remarkable recoveries.
Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.
Hand Technologies, LLC (HAND) is a startup committed to developing and commercializing high-performance polymers and ultra-high temperature carbon/ceramic materials for the U.S. aerospace and defense market.
We developed SANDI (Simulator for Advanced Neurodiverse Driving Instruction), an AI-driven virtual reality driving simulator designed to help individuals on the autism spectrum build confidence, learn driving skills, and overcome driving anxiety through adaptive training and physiological feedback systems.
We are making the world more accessible by giving transportation businesses the Artificial Intelligence they need for vehicle scheduling, routing, and energy-use management.
Augment Health is transforming the $12.3B urodynamics market by replacing complex in-clinic testing with the first at-home monitoring system, immediately unlocking significant revenue opportunities for clinics while solving a critical access gap for 200K patients actively seeking care.
